What to Expect During and After Simponi Aria Infusion Side Effects and Monitoring

Simponi Aria, known by its generic name golimumab, represents a significant advancement in the treatment of chronic inflammatory conditions. As a tumor necrosis factor (TNF) blocker, it is specifically designed to target and neutralize a protein in the body that causes inflammation. While it is highly effective for managing rheumatoid arthritis (RA), psoriatic arthritis (PsA), ankylosing spondylitis (AS), and polyarticular juvenile idiopathic arthritis (pJIA), its systemic impact on the immune system leads to a range of potential side effects.

Understanding the side effect profile of Simponi Aria is essential for any patient undergoing this intravenous (IV) therapy. Because the medication is administered directly into the bloodstream through a 30-minute infusion, it interacts with the immune system rapidly. This guide provides a detailed breakdown of what may occur during the infusion, in the days following treatment, and over the long term.

Immediate Infusion Reactions During the 30-Minute Procedure

Unlike medications taken orally or through subcutaneous injection, Simponi Aria is delivered in a clinical setting under the supervision of healthcare professionals. One of the primary categories of side effects involves "infusion reactions," which occur while the medication is being administered or shortly thereafter.

In clinical trials, approximately 1.1% of patients experienced an infusion reaction. While this percentage is relatively low, the nature of these reactions requires immediate attention.

Common Sensations During Infusion

During the 30 minutes that the IV drip is active, some patients report localized or systemic sensations. These are often mild and may include:

Temperature changes: A feeling of coolness in the arm where the IV is inserted as the diluted saline solution enters the vein.
Dizziness or Lightheadedness: This can be a reaction to the medication itself or sometimes a vasovagal response to the needle or the clinical environment.
Headache: A dull ache may begin during the infusion or peak a few hours later.

Signs of Hypersensitivity

More serious immediate reactions are classified as hypersensitivity. Medical staff monitor for these symptoms throughout the procedure:

Skin Changes: The sudden appearance of hives, a red rash, or intense itching (pruritus).
Respiratory Distress: Feeling a tightness in the chest, shortness of breath, or wheezing. In our clinical observations, this is often the most distressing symptom for patients and requires stopping the infusion immediately.
Swelling: Known as angioedema, this involves swelling of the lips, tongue, or throat, which can obstruct the airway.

Healthcare providers often pre-medicate patients with antihistamines or acetaminophen if they have a history of mild reactions to help mitigate these immediate effects.

Common Side Effects Reported in Clinical Trials

Beyond the immediate window of the infusion, Simponi Aria can cause several common side effects as it begins to modulate the immune response. These reactions were documented in large-scale studies such as the GO-VIBRANT and GO-ALIVE trials.

Upper Respiratory and Viral Infections

Because Simponi Aria lowers the body's ability to fight off pathogens, respiratory issues are the most frequently reported side effect.

The Common Cold and Flu: Patients often report symptoms like a runny nose, sore throat, and sneezing. These viral infections may last longer or feel more intense than they did prior to starting biologic therapy.
Bronchitis: Inflammation of the bronchial tubes is common, often presenting as a persistent cough with mucus production.
Sinusitis: Pain and pressure around the eyes and cheeks, often accompanied by nasal congestion.

Elevated Liver Enzymes

A notable side effect discovered during clinical testing is the impact on liver function. Specifically, levels of Alanine Aminotransferase (ALT) and Aspartate Aminotransferase (AST) may increase.

Incidence Rates: In studies of psoriatic arthritis, ALT increases occurred in about 7.9% of Simponi Aria patients compared to 2.1% in the placebo group.
Significance: While most elevations are mild, they indicate that the liver is under stress. This is why regular blood work is a mandatory part of the Simponi Aria treatment protocol.

Blood Pressure and Vascular Changes

Hypertension, or high blood pressure, has been observed in more than 3% of patients. This may be a new onset of high blood pressure or a worsening of pre-existing hypertension. Patients are advised to monitor their blood pressure at home, especially in the week following an infusion.

Understanding the FDA Boxed Warnings for Serious Risks

The FDA requires a "Boxed Warning" for Simponi Aria, which is the most serious type of warning for prescription medications. These warnings focus on two primary areas: serious infections and malignancy.

Serious Infections and Reactivation

Simponi Aria suppresses the immune system's inflammatory response, which is necessary for fighting serious diseases.

Tuberculosis (TB): There is a risk of activating "latent" TB. This is why a TB skin or blood test is required before the first infusion. Even if the initial test is negative, patients must be monitored for symptoms like a persistent cough, weight loss, and low-grade fever.
Bacterial Sepsis: In rare cases, infections can spread to the bloodstream, leading to life-threatening sepsis.
Invasive Fungal Infections: Conditions like histoplasmosis or coccidioidomycosis are a risk, particularly for patients living in or traveling to the Ohio and Mississippi River valleys or the Southwest.
Hepatitis B Reactivation: For those who are carriers of the Hepatitis B virus, the medication can cause the virus to become active again, potentially leading to liver failure or death.

Risk of Malignancy (Cancer)

The role of TNF in the body includes identifying and destroying abnormal cells. By blocking TNF, there is a theoretical and observed increase in certain cancers.

Lymphoma: This is a cancer of the lymphatic system. While rare, it has been reported more frequently in patients taking TNF blockers than in the general population.
Hepatosplenic T-cell Lymphoma (HSTCL): This is an extremely rare and often fatal type of lymphoma that has occurred primarily in adolescents and young adults using TNF blockers.
Skin Cancer: Both melanoma and non-melanoma skin cancers have been reported. Regular dermatological exams are recommended for all patients on Simponi Aria.

Systemic and Long-Term Health Considerations

As treatment continues over months and years, Simponi Aria may affect other organ systems. These side effects are less common but require vigilant monitoring.

New or Worsening Heart Failure

TNF blockers have been associated with the worsening of congestive heart failure (CHF).

Symptoms to Watch: Sudden shortness of breath, especially when lying down, swelling in the ankles or feet, and rapid weight gain (often 3-5 pounds in a single day due to fluid retention).
Contraindications: Patients with severe heart failure may not be candidates for this medication.

Demyelinating Disorders

In very rare instances, Simponi Aria can affect the nervous system, specifically the protective coating around nerves (myelin).

Multiple Sclerosis (MS) Like Symptoms: Patients should report any new onset of numbness, tingling sensations, vision changes, or muscle weakness.
Guillain-Barré Syndrome: Though exceptionally rare, any sudden loss of coordination or severe muscle weakness should be treated as a medical emergency.

Immune System Reactions and Lupus-like Syndrome

Ironically, a medication used to treat autoimmune disease can sometimes trigger a different autoimmune response.

Lupus-like Syndrome: Symptoms include joint pain, a rash on the cheeks or arms that worsens in the sun, and extreme fatigue. If a patient develops antibodies against their own DNA along with these symptoms, the medication is typically discontinued.

Blood Disorders (Cytopenias)

The medication can lead to a decrease in blood cells produced by the bone marrow.

Neutropenia: A low count of white blood cells, which significantly increases infection risk.
Thrombocytopenia: A low platelet count, which can lead to easy bruising or prolonged bleeding from minor cuts.

Monitoring and Laboratory Tests During Treatment

Because of the potential for "silent" side effects—those you cannot feel, such as liver enzyme elevation or low white blood cell counts—regular testing is a vital part of the therapy.

Pre-Treatment Screening

Before the first 30-minute infusion, a baseline must be established:

TB Testing: Quantiferon Gold or a TST skin test.
Hepatitis Panel: Specifically checking for HBV surface antigens.
Comprehensive Metabolic Panel (CMP): To check baseline liver and kidney function.
Complete Blood Count (CBC): To ensure bone marrow function is normal.

Ongoing Monitoring Schedule

Typically, after the loading doses (Week 0 and Week 4), infusions occur every 8 weeks. Most rheumatologists order blood work:

Every 8 to 12 weeks: Checking ALT, AST, and CBC.
Annually: A repeat TB test may be required depending on local risk factors.

Managing and Reporting Side Effects

Managing side effects involves a partnership between the patient and the rheumatology team.

What to Do for Mild Reactions

For common issues like headaches or mild upper respiratory symptoms:

Rest and Hydration: Especially in the 24 hours following an infusion.
Over-the-Counter Support: Use of saline nasal sprays for congestion or acetaminophen for headaches, provided these are cleared by your doctor.
Journaling: Keeping a "treatment diary" to note when symptoms appear relative to the infusion date. This helps the doctor determine if the side effects are transient or worsening.

When to Seek Immediate Medical Help

Certain symptoms should never be ignored. Contact your healthcare provider or seek emergency care if you experience:

Fever over 101°F or chills.
Open sores that will not heal.
Persistent cough or coughing up blood.
Severe abdominal pain or yellowing of the skin (jaundice).
Sudden changes in vision or balance.

Conclusion

Simponi Aria is a powerful biologic tool that provides relief for thousands of patients with debilitating autoimmune conditions. However, its effectiveness is balanced by a complex side effect profile. While the majority of patients experience only mild symptoms like upper respiratory infections or temporary headaches, the potential for serious infections and long-term risks like malignancy requires a commitment to safety.

By staying informed about the 30-minute infusion process, adhering to the strict laboratory monitoring schedule, and maintaining open communication with a rheumatologist, patients can maximize the benefits of Simponi Aria while minimizing the impact of its side effects.

FAQ

How long do Simponi Aria side effects last? Immediate infusion reactions usually resolve within 24 hours. Common side effects like respiratory infections or headaches may occur periodically throughout the 8-week dosing cycle. Serious risks, such as the impact on the liver or immune system, persist as long as the medication is active in the body.

Can I get vaccines while on Simponi Aria? You should avoid "live" vaccines (such as the flu mist or certain shingles vaccines) because the medication weakens your immune system's ability to handle even weakened viruses. Always consult your doctor before any vaccination.

Does Simponi Aria cause weight gain? Weight gain is not a common direct side effect of the medication. However, sudden weight gain can be a sign of fluid retention related to heart failure, which is a serious side effect that must be reported immediately.

Will the infusion make me tired? Fatigue is a commonly reported experience following the infusion. This is often the body's reaction to the immune system modulation and typically improves after a day or two of rest.

What is the most common side effect? Statistically, upper respiratory tract infections (the common cold, sore throat) are the most frequently reported side effects in clinical trials, occurring in over 10% of patients in some long-term studies.